Combined with the conventional clinical predictors, including age, gender and baseline ALT levels, a subgroup of cirrhotic patients (~30%) was identified with a particularly high risk of HCC compared with other cirrhotic patients (P = 0.001). The gene discussed is GPT; the disease is hepatocellular carcinoma.